bibliographic entry 7573940 [be/7573940]
https://w3id.org/oc/corpus/be/7573940

is a
content
  • Heise, T, Seewaldt-Becker, E, Macha, S, Hantel, S, Pinnetti, S, Seman, L, Woerle, HJ. Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks’ treatment with empagliflozin once daily in patients with type 2 diabetes. Diabetes Obes Metab 2013; 15: 613–621. PMID: 23356556
references